Risk factors for blood transfusion in traumatic and postpartum hemorrhage patients: Analysis of the CRASH-2 and WOMAN trials

David A Kolin, Haleema Shakur-Still, Adenike Bello, Rizwana Chaudhri, Imelda Bates, Ian Roberts, David A Kolin, Haleema Shakur-Still, Adenike Bello, Rizwana Chaudhri, Imelda Bates, Ian Roberts

Abstract

Background: Hemorrhage is a leading cause of death after trauma and childbirth. In response to severe hemorrhage, bleeding patients often receive transfusions of red blood cells, plasma, platelets, or other blood components. We examined risk factors for transfusion in acute severe bleeding in two trials of over 20,000 patients to better understand factors associated with transfusion likelihood.

Study design and methods: We conducted a cohort analysis of data from the CRASH-2 and WOMAN trials, two multinational trials that recruited patients with traumatic and postpartum hemorrhage, respectively. For each trial, we examined the effect of 10 factors on blood transfusion likelihood. Univariate and multivariate Poisson regressions were used to analyze the relationship between risk factors and blood transfusion.

Results: Of the 20,207 traumatic hemorrhage patients, 10,232 (51%) received blood components. Of the 20,060 women with postpartum hemorrhage, 10,958 (55%) received blood components. For patients who suffered from traumatic hemorrhage, those greater than three hours from injury to hospitalization were more likely to be transfused (ARR 1.37; 95% CI, 1.20-1.56). Postpartum hemorrhage patients had an increased likelihood of transfusion if they gave birth outside the hospital (ARR 1.30; 95% CI 1.22-1.39), gave birth more than three hours before hospitalization (ARR 1.09; 95% CI 1.01-1.17), had a Caesarean section (ARR 1.16; 95% CI 1.08-1.25), and if they had any identifiable causes of hemorrhage other than uterine atony.

Conclusion: Several risk factors are associated with an increased likelihood of transfusion in traumatic and postpartum hemorrhage patients. Altering modifiable factors, by reducing time from injury or childbirth to hospitalization, for example, might be able to reduce transfusions and their complications.

Trial registration: CRASH-2 is registered as ISRCTN86750102, ClinicalTrials.gov NCT00375258 and South African Clinical Trial Register DOH-27-0607-1919. WOMAN is registered as ISRCTN76912190, ClinicalTrials.gov NCT00872469, PACTR201007000192283, and EudraCT number 2008-008441-38.

Conflict of interest statement

With respect to Pfizer, the commercial funder for this trial, there are no other relevant declarations including any declarations related to employment, consultancy, patents, products in development, marketed products, etc. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1
The frequency of blood transfusion volumes differs by country income group in traumatic hemorrhage patients: high-income (A), upper-middle-income (B), lower-middle-income (C), and low-income (D).
Fig 2
Fig 2
The frequency of blood transfusion volumes differs by country income group in postpartum hemorrhage patients: high-income (A), upper-middle-income (B), lower-middle-income (C), and low-income (D).

References

    1. World Health Organization. The scale of the problem. Global burden of disease; 2004.
    1. Gosselin R. Injuries: the neglected burden in developing countries. Bulletin of the World Health Organization. 2009. April 1;87(4):246–246.
    1. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, et al. Management of bleeding following major trauma: an updated European guideline. Critical Care. 2010;14(2):R52.
    1. Curry N, Hopewell S, Dorée C, Hyde C, Brohi K, Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Critical Care. 2011;15(2):R92.
    1. Brohi K, Singh J, Heron M, Coats T. Acute Traumatic Coagulopathy: The Journal of Trauma: Injury, Infection, and Critical Care. 2003. June;54(6):1127–30.
    1. Frith D, Goslings JC, Gaarder C, Maegele M, Cohen MJ, Allard S, et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations: Acute traumatic coagulopathy. Journal of Thrombosis and Haemostasis. 2010. September;8(9):1919–25.
    1. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Practice & Research Clinical Obstetrics & Gynaecology. 2008. Dec;22(6):999–1012.
    1. World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. World Health Organization; 2012.
    1. Combs CA, Murphy EL, Laros RK. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol. 1991. January;77(1):69–76.
    1. Magann EF, Evans S, Hutchinson M, Collins R, Howard BC, Morrison JC. Postpartum hemorrhage after vaginal birth: an analysis of risk factors. South Med J. 2005. April;98(4):419–22.
    1. Snelgrove JW. Postpartum haemorrhage in the developing world a review of clinical management strategies. Mcgill J Med. 2009. November 16;12(2):61.
    1. National Heart, Lung, and Blood Institute. Blood transfusion [Internet]. [cited 2018 Jun 26]. Available from:
    1. Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Physician. 2011. March 15;83(6):719–24.
    1. Paydar S, Sabetian G, Khalili H, Abbasi HR, Bolandparvaz S, Ghahramani Z, et al. Shiraz Trauma Transfusion Score: A Scoring System for Blood Transfusion in Trauma Patients. Bull Emerg Trauma. 2016. July;4(3):121–3.
    1. World Health Organization. Global Status Report on Blood Safety and Availability. 2016.
    1. Kyeyune-Byabazaire D, Hume HA. Towards a safe and sufficient blood supply in Sub-Saharan Africa. ISBT Science Series. 2019. February;14(1):104–13.
    1. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. The Lancet. 2010. July;376(9734):23–32.
    1. CRASH Trials Co-ordinating Centre Management Group. CRASH-2 Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage: Protocol [Internet]. 2005 [cited 2018 Jun 27]. Available from:
    1. The WOMAN Trial Protocol Committee. Tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Clinical Trial Protocol; 2014.
    1. Shakur H, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, Akintan A, et al. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. The Lancet. 2017. May;389(10084):2105–16.
    1. How does the World Bank classify countries? [Internet]. The World Bank; Available from:
    1. Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early Prediction of Massive Transfusion in Trauma: Simple as ABC (Assessment of Blood Consumption)?: The Journal of Trauma: Injury, Infection, and Critical Care. 2009. February;66(2):346–52.
    1. Ilancheran A, Rahman F, Mitra B. Indications for blood transfusion following trauma—a pilot study. Journal of Emergency Medicine, Trauma and Acute Care. 2015. January;2015(1):4.
    1. Oya A, Nakai A, Miyake H, Kawabata I, Takeshita T. Risk factors for peripartum blood transfusion in women with placenta previa: a retrospective analysis. J Nippon Med Sch. 2008. June;75(3):146–51.
    1. Wikkelsø AJ, Hjortøe S, Gerds TA, Møller AM, Langhoff-Roos J. Prediction of postpartum blood transfusion—risk factors and recurrence. J Matern Fetal Neonatal Med. 2014. November;27(16):1661–7.
    1. Chen W, Qian L, Shi J, Franklin M. Comparing performance between log-binomial and robust Poisson regression models for estimating risk ratios under model misspecification. BMC Medical Research Methodology [Internet]. 2018. December [cited 2019 Feb 17];18(1). Available from:
    1. Zou G. A Modified Poisson Regression Approach to Prospective Studies with Binary Data. American Journal of Epidemiology. 2004. April 1;159(7):702–6.
    1. Jenny HE, Saluja S, Sood R, Raykar N, Kataria R, Tongaonkar R, et al. Access to safe blood in low-income and middle-income countries: lessons from India. BMJ Global Health. 2017. May;2(2):bmjgh-2016-000167.
    1. Kralievits KE, Raykar NP, Greenberg SLM, Meara JG. The global blood supply: a literature review. The Lancet. 2015. April;385:S28.
    1. McNutt L-A. Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes. American Journal of Epidemiology. 2003. May 15;157(10):940–3.
    1. Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, Triulzi D, Doree C, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Injuries Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2016. October 12 [cited 2018 Jun 18]; Available from:
    1. Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical review: hemorrhagic shock. Crit Care. 2004. October;8(5):373–81.
    1. Wu S-C, Rau C-S, Kuo SCH, Hsu S-Y, Hsieh H-Y, Hsieh C-H. Shock index increase from the field to the emergency room is associated with higher odds of massive transfusion in trauma patients with stable blood pressure: A cross-sectional analysis. Cheungpasitporn W, editor. PLOS ONE. 2019. April 25;14(4):e0216153.
    1. Schroll R, Swift D, Tatum D, Couch S, Heaney JB, Llado-Farrulla M, et al. Accuracy of shock index versus ABC score to predict need for massive transfusion in trauma patients. Injury [Internet]. 2017. September [cited 2017 Dec 3]; Available from:
    1. Evensen A, Anderson JM, Fontaine P. Postpartum Hemorrhage: Prevention and Treatment. Am Fam Physician. 2017. April 1;95(7):442–9.
    1. Roberts DJ, Field S, Delaney M, Bates I. Problems and Approaches for Blood Transfusion in the Developing Countries. Hematology/Oncology Clinics of North America. 2016. April;30(2):477–95.
    1. Custer B, Zou S, Glynn SA, Makani J, Tayou Tagny C, El Ekiaby M, et al. Addressing gaps in international blood availability and transfusion safety in low- and middle-income countries: a NHLBI workshop: blood availability and transfusion safety in LMICs. Transfusion. 2018. May;58(5):1307–17.
    1. Smit Sibinga CTh Abdella YE. Availability and safety of blood transfusion in low- and middle-income countries: availability and safety of blood. Transfusion [Internet]. 2019. February 27 [cited 2019 Apr 4]; Available from:
    1. Balarajan Y, Ramakrishnan U, Özaltin E, Shankar AH, Subramanian S. Anaemia in low-income and middle-income countries. The Lancet. 2011. December;378(9809):2123–35.
    1. World Health Organization. Prevalence of anemia among pregnant women (%) [Internet]. Global Health Observatory Data Repository/World Health Statistics; 2016. Available from:
    1. World Health Organization. Prevalence of anemia among non-pregnant women (% of women ages 15–49) [Internet]. Global Health Observatory Data Repository/World Health Statistics; 2016. Available from:
    1. Trinh LTT, Dibley M. Anaemia in pregnant, postpartum and non pregnant women in Lak district, Daklak province of Vietnam. Asia Pac J Clin Nutr. 2007;16(2):310–5.
    1. Berger MD, Gerber B, Arn K, Senn O, Schanz U, Stussi G. Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation. Haematologica. 2012. January 1;97(1):116–22.
    1. Thakkar R, Podlasek S, Rotello L, Ness P, Frank S. Two-Unit Red Cell Transfusions in Stable Anemic Patients. Journal of Hospital Medicine. 2017. September;12(9):747–9.
    1. Heyes J, Kelly PA, Monaghan K, Lawn M, Dhesi A, Mijovic A. A single unit transfusion policy reduces red cell transfusions in general medical in-patients. QJM: An International Journal of Medicine. 2017. November 1;110(11):735–9.
    1. Frass KA. Postpartum hemorrhage is related to the hemoglobin levels at labor: Observational study. Alexandria Journal of Medicine. 2015. December;51(4):333–7.
    1. Benedict N, Augustina A, Nosakhare B. Blood Donation in Nigeria: Standard of the Donated Blood. Journal of Laboratory Physicians. 2012;4(2):94.
    1. Akingbola TS. Obstetric Emergencies and Transfusion Needs in a Nigerian Hospital. Hematology & Transfusion International Journal [Internet]. 2016. July 30 [cited 2019 May 2];2(6). Available from:
    1. Roberts I, Shakur H, Fawole B, Kuti M, Olayemi O, Bello A, et al. Haematological and fibrinolytic status of Nigerian women with post-partum haemorrhage. BMC Pregnancy and Childbirth [Internet]. 2018. December [cited 2019 May 2];18(1). Available from:
    1. Cheraghali AM. Blood safety concerns in the Eastern Mediterranean region. Hepat Mon. 2011. June;11(6):422–6.
    1. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev J. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ. 2015. March 24;350(mar24 9):h1354–h1354.
    1. Hirano Y, Miyoshi Y, Kondo Y, Okamoto K, Tanaka H. Liberal versus restrictive red blood cell transfusion strategy in sepsis or septic shock: a systematic review and meta-analysis of randomized trials. Critical Care [Internet]. 2019. December [cited 2020 Jan 20];23(1). Available from:
    1. Estcourt LJ, Malouf R, Trivella M, Fergusson DA, Hopewell S, Murphy MF. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support. Cochrane Haematological Malignancies Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2017. January 27 [cited 2020 Jan 20]; Available from:
    1. Hong D-H, Kim E, Kyeong K-S, Hong SH, Jeong E-H. Safety of cesarean delivery through placental incision in patients with anterior placenta previa. Obstet Gynecol Sci. 2016. March;59(2):103–9.
    1. Liu Y, Li G, Chen Y, Wang X, Ruan Y, Zou L, et al. A descriptive analysis of the indications for caesarean section in mainland China. BMC Pregnancy and Childbirth [Internet]. 2014. December [cited 2019 Jun 29];14(1). Available from:
    1. Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Pregnancy and Childbirth Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2014. February 12 [cited 2019 Jun 29]; Available from:
    1. Sebghati M, Chandraharan E. An update on the risk factors for and management of obstetric haemorrhage. Women’s Health. 2017. August;13(2):34–40.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe